2019
DOI: 10.1186/s12872-019-1041-3
|View full text |Cite
|
Sign up to set email alerts
|

Associations between ADIPOQ polymorphisms and coronary artery disease: a meta-analysis

Abstract: BackgroundWhether adiponectin (ADIPOQ) polymorphisms are associated with coronary artery disease (CAD) remain controversial. Therefore, we performed this meta-analysis to better explore potential roles of ADIPOQ polymorphisms in CAD.MethodsPubMed, Web of Science, Embase and CNKI were searched for eligible studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.ResultsTotally 45 studies were included for pooled analyses. A significant association with the susceptibility to CAD was detected… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…These genes all have negative SLPs, suggesting that rare variants impacting their functioning might tend to be protective against hyperlipidaemia. ADIPOQ (SLP=-1.37) codes for adiponectin, an adipokine which is expressed in adipocytes which influences fat metabolism, and common variants in the gene are associated with cardiovascular disease risk and lipid levels (Liu et al, 2018;Salazar-Tortosa et al, 2020;Wang et al, 2019;Zhang et al, 2019). Adiponectin has a hypoglycaemic effect and can reverse the insulin resistance associated with both lipoatrophy and obesity (Berg et al, 2001;Yamauchi et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…These genes all have negative SLPs, suggesting that rare variants impacting their functioning might tend to be protective against hyperlipidaemia. ADIPOQ (SLP=-1.37) codes for adiponectin, an adipokine which is expressed in adipocytes which influences fat metabolism, and common variants in the gene are associated with cardiovascular disease risk and lipid levels (Liu et al, 2018;Salazar-Tortosa et al, 2020;Wang et al, 2019;Zhang et al, 2019). Adiponectin has a hypoglycaemic effect and can reverse the insulin resistance associated with both lipoatrophy and obesity (Berg et al, 2001;Yamauchi et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…[ 49 ] Besides, phytosterols compete for the Neiman Pick C1‐Like 1 transporter on enterocytes with exogenous intestinal cholesterol, then reducing cholesterol absorption. [ 50 ] Adiponectin plays an anti‐atherogenic role by regulating lipid metabolism, [ 51 ] and ADIPOQ is a lipid cytokine that regulates energy and substance metabolism, and the high activity of ADIPOQ gene is one of the key factors contributing to adiponectin production. [ 52 ] ADIPOQ has anti‐inflammatory and anti‐insulin resistance effects.…”
Section: Discussionmentioning
confidence: 99%
“…The meta-analyses stated that the allele of variant G rs2241766 was negatively associated with the risk of metabolically controlled obesity; the allele of variant T rs1501299 displayed a decrease in the chances for metabolically controlled obesity and metabolically uncontrolled normal weight in the Chinese population [ 25 ]. Additionally, according to the study of Howlader et al [ 6 ], two single-nucleotide polymorphisms of ADIPOQ (rs2241766 and rs1501299) were associated with the risk of dyslipidemia; polymorphism rs1501299 was significantly associated with a susceptibility to ischemic heart disease in East Asia polymorphism rs2241766 was directly related to ischemic heart disease in Europe, East Asia and South Asia [ 26 ].…”
Section: Discussionmentioning
confidence: 99%